Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

Recursion Pharmaceuticals is transforming drug discovery with AI-driven RecursionOS, slashing costs and boosting development ...

Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with ...

UB scientists Ram Samudrala, PhD, and Zackary M. Falls, PhD, talk about the new platform to make drug discovery faster and less expensive while also being safe and effective.

Schrödinger, Inc. (NASDAQ:SDGR) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Schrödinger, Inc. ...

A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts ...

Despite the impressive and undeniable strides quantum computing has made in recent years, it’s important to remain cautious ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...